|
121
|
|
|
- |
ROA1 |
|
|
122
|
|
|
OTU deubiquitinase, ubiquitin aldehyde binding 2 |
C14orf137, OTB2, OTU2 |
|
|
123
|
|
|
Olfactory receptor family 7 subfamily E member 94 pseudogene |
- |
|
|
124
|
|
|
Olfactory receptor family 2 subfamily H member 2 |
FAT11, OLFR2, OLFR42B, OR2H3, dJ271M21.2, hs6M1-12 |
|
|
125
|
|
|
Olfactory receptor family 10 subfamily R member 1 pseudogene |
OR1-10 |
|
|
126
|
|
|
Outer mitochondrial membrane lipid metabolism regulator OPA3 |
MGA3 |
Capsular cataract, Cataract, Cerebellar atrophy, Choreoathetosis, Color blindness, Disorder of eye, Dysarthria, Dyslexia, Impaired cognition, Mental retardation, Nystagmus, Optic atrophy, Optic atrophy and cataract, Subcapsular cataract |
|
127
|
|
|
Olfactory receptor family 10 subfamily Q member 2 pseudogene |
- |
|
|
128
|
|
|
Olfactory receptor family 5 subfamily V member 1 |
6M1-21, hs6M1-21 |
Asthma, Barrett esophagus, Breast carcinoma, Development disorder, Diabetes mellitus, Esophageal cancer, Lung cancer, Lupus erythematosus, Rheumatoid arthritis, Sarcoidosis, Schizophrenia |
|
129
|
|
|
Olfactory receptor family 2 subfamily B member 2 |
OR2B2Q, OR2B9, OR6-1, dJ193B12.4, hs6M1-10 |
|
|
130
|
|
|
Olfactory receptor family 12 subfamily D member 3 |
hs6M1-27 |
Asthma, Barrett esophagus, Breast cancer, Breast carcinoma, Development disorder, Diabetes, Diabetes mellitus, Esophageal cancer, Lung cancer, Lupus erythematosus, Mental depression, Rheumatoid arthritis, Sarcoidosis, Schizophrenia |
